SCHOTT MINIFAB Acquires Applied Microarrays Inc.

Lattice Semiconductor To Acquire AMI in $1.65 Billion Deal

May 6, 2026

AI & Machine Learning

Lattice Semiconductor entered into a definitive agreement to acquire AMI from THL Partners in a transaction valued at approximately $1.65 billion. The deal combines Lattice’s low-power FPGA technology with AMI’s platform firmware and infrastructure manageability software for cloud and AI systems.

GlobalFoundries Acquires Advanced Micro Foundry

November 18, 2025

Manufacturing

GlobalFoundries (GF) has acquired Singapore-based Advanced Micro Foundry (AMF), expanding GF's silicon photonics manufacturing capabilities and establishing GF as the largest pure-play silicon photonics foundry by revenue. The deal brings AMF's 200mm manufacturing platform, IP and talent into GF's global operations and includes plans to scale production and open a silicon photonics R&D center of excellence in Singapore.

Spectrum Solutions Acquires Alimetrix, Inc. and Microarrays, Inc.

March 7, 2023

Healthcare Services

Spectrum Solutions has acquired Alimetrix, Inc., a CLIA- and CAP-accredited molecular diagnostic laboratory, and Microarrays, Inc., a manufacturer of array-based research and diagnostic products. The acquisitions expand Spectrum's assay development, clinical testing and array-manufacturing capabilities to accelerate its decentralized testing platform and go-to-market strategies.

ARCHIMED Invests in PlasmidFactory

October 7, 2022

Biotechnology

Transatlantic healthcare private equity firm ARCHIMED (via its MED Platform II fund) has invested in PlasmidFactory, a Bielefeld, Germany-based contract manufacturer of plasmid and minicircle DNA used in gene and cell therapies. The founder and management will remain in place with a roll-over of a portion of proceeds; proceeds will fund rapid expansion including construction of a larger GMP-compliant production facility to meet growing demand.

Thermo Fisher Scientific Acquires Affymetrix

March 31, 2016

Biotechnology

Thermo Fisher Scientific has completed its acquisition of Affymetrix for $14.00 per share in cash, representing an approximate total purchase price of $1.3 billion, following approval by Affymetrix stockholders. The deal brings Affymetrix's genetic analysis products and expanded antibody portfolio into Thermo Fisher's life sciences offerings to strengthen its capabilities in biosciences and clinical/applied markets.

Affymetrix Acquires Panomics for Approximately $73M

November 11, 2008

Biotechnology

Affymetrix Inc. agreed to acquire Panomics Inc., a Fremont, California–based provider of low- to mid-plex genetic and protein assay products, for approximately $73 million in cash. The purchase is intended to expand Affymetrix's product portfolio and enable a more complete genetic-analysis workflow—linking whole-genome microarray studies with targeted Panomics assays—and is expected to close by the end of 2008 subject to customary conditions.